134 related articles for article (PubMed ID: 26215676)
21. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
22. Aberrant microRNA expression in radiation-induced rat mammary cancer: the potential role of miR-194 overexpression in cancer cell proliferation.
Iizuka D; Imaoka T; Nishimura M; Kawai H; Suzuki F; Shimada Y
Radiat Res; 2013 Feb; 179(2):151-9. PubMed ID: 23273170
[TBL] [Abstract][Full Text] [Related]
23. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland.
Bradbury JM; Arno J; Edwards PA
Oncogene; 1993 Jun; 8(6):1551-8. PubMed ID: 8099220
[TBL] [Abstract][Full Text] [Related]
24. Identification of differentially expressed microRNAs during the development of Chinese murine mammary gland.
Wang C; Li Q
J Genet Genomics; 2007 Nov; 34(11):966-73. PubMed ID: 18037133
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.
Bockmeyer CL; Christgen M; Müller M; Fischer S; Ahrens P; Länger F; Kreipe H; Lehmann U
Breast Cancer Res Treat; 2011 Dec; 130(3):735-45. PubMed ID: 21409395
[TBL] [Abstract][Full Text] [Related]
27. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic miR-17/20a Forms a Positive Feed-forward Loop with the p53 Kinase DAPK3 to Promote Tumorigenesis.
Cai Z; Cao R; Zhang K; Xue Y; Zhang C; Zhou Y; Zhou J; Sun H; Fu XD
J Biol Chem; 2015 Aug; 290(32):19967-75. PubMed ID: 26117336
[TBL] [Abstract][Full Text] [Related]
29. miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy.
Rodriguez-Barrueco R; Nekritz EA; Bertucci F; Yu J; Sanchez-Garcia F; Zeleke TZ; Gorbatenko A; Birnbaum D; Ezhkova E; Cordon-Cardo C; Finetti P; Llobet-Navas D; Silva JM
Genes Dev; 2017 Mar; 31(6):553-566. PubMed ID: 28404630
[TBL] [Abstract][Full Text] [Related]
30. The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer.
Greene SB; Herschkowitz JI; Rosen JM
RNA Biol; 2010; 7(3):300-4. PubMed ID: 20436283
[TBL] [Abstract][Full Text] [Related]
31. A Sucrose-Enriched Diet Promotes Tumorigenesis in Mammary Gland in Part through the 12-Lipoxygenase Pathway.
Jiang Y; Pan Y; Rhea PR; Tan L; Gagea M; Cohen L; Fischer SM; Yang P
Cancer Res; 2016 Jan; 76(1):24-9. PubMed ID: 26729790
[TBL] [Abstract][Full Text] [Related]
32. CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs.
De Luca P; Dalton GN; Scalise GD; Moiola CP; Porretti J; Massillo C; Kordon E; Gardner K; Zalazar F; Flumian C; Todaro L; Vazquez ES; Meiss R; De Siervi A
Oncotarget; 2016 Apr; 7(14):18798-811. PubMed ID: 26933806
[TBL] [Abstract][Full Text] [Related]
33. Tenascin in mammary gland development: from embryogenesis to carcinogenesis.
Sakakura T; Ishihara A; Yatani R
Cancer Treat Res; 1991; 53():383-400. PubMed ID: 1705813
[No Abstract] [Full Text] [Related]
34. Embryonic mammary gland development; a domain of fundamental research with high relevance for breast cancer research. Preface.
Howard BA; Veltmaat JM
J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):89-91. PubMed ID: 23686554
[No Abstract] [Full Text] [Related]
35. The miR-200 family in normal mammary gland development.
Roth MJ; Moorehead RA
BMC Dev Biol; 2021 Aug; 21(1):12. PubMed ID: 34454436
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs in the development and neoplasia of the mammary gland.
Jena MK
F1000Res; 2017; 6():1018. PubMed ID: 28979765
[TBL] [Abstract][Full Text] [Related]
37. Paternal overweight is associated with increased breast cancer risk in daughters in a mouse model.
Fontelles CC; Carney E; Clarke J; Nguyen NM; Yin C; Jin L; Cruz MI; Ong TP; Hilakivi-Clarke L; de Assis S
Sci Rep; 2016 Jun; 6():28602. PubMed ID: 27339599
[TBL] [Abstract][Full Text] [Related]
38. Models of breast cancer: is merging human and animal models the future?
Kim JB; O'Hare MJ; Stein R
Breast Cancer Res; 2004; 6(1):22-30. PubMed ID: 14680482
[TBL] [Abstract][Full Text] [Related]
39. Mammogenesis and breast carcinogenesis in virgin female mice of BALB/cf substrain with the milk agent.
SQUARTINI F
J Natl Cancer Inst; 1959 Dec; 23():1227-38. PubMed ID: 13833519
[No Abstract] [Full Text] [Related]
40. The relevance of mouse models to understanding the development and progression of human breast cancer.
Allred DC; Medina D
J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):279-88. PubMed ID: 18704660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
